top of page

"Acute Stroke Trials: Advancing Design,

Implementation and Regulation"

STAIR IX Sponsors

Genentech, Inc

Medtronic

Penumbra, Inc.

Shin Poong Pharm, CO., LTD

Codman Neuro

Stryker Neurovascular

MicroVention, Inc.

Lumosa Therapeutics, Co., Ltd.

Bayer Healthcare, LLC

BrainsGate Ltd.

Fraunhofer-Institute

GE Healthcare

iSchemaView Inc.

Pulse Therapeutics, Ltd.

Neuravi, Ltd.

Omniox, Inc.

Siemens

Toshiba America

Medical Systems, Inc.

ZZ Biotech, Ltd.

InNeuroCo, Inc.

The information contained in this website reflects opinions of STAIR participants regarding the process of conducting research and development into existing, new and prospective drugs and devices for the treatment of stroke. The information is not intended to be a substitute for rigorous independent testing and development of individual compounds and devices by research sponsors, nor should the information and opinions be construed as official government regulations or official interpretations of government regulations. All government regulations and their applications to specific research studies and clinical trials are subject to individual deliberations between study sponsors and government agencies. The information contained in this website is not intended to be a substitute for sound medical advice, clinical judgment or informed treatment decisions.

STAIR® is a Registered Trademark of The Stroke Group.   

© 2025 The Stroke Group

bottom of page